From the moment Covid-19 emerged as a threat, one approach to making drugs to treat or prevent the disease seemed to hold the most promise: They’re known as monoclonal antibodies. Now, scientists are on the brink of getting important data that may indicate whether these desperately needed therapies could be safe and effective.